XML 20 R9.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Segment Reporting
 6 Months Ended
Jun. 30, 2011
Segment Reporting [Abstract]  
SEGMENT REPORTING
(3) SEGMENT REPORTING
We operate in one segment, specialty pharmaceutical products. Management has chosen to organize the Company based on the type of products sold. All of our assets are located in the United States. We did not have any sales to non-U.S. customers during the three months ended June 30, 2011 and 2010, respectively. We had sales of less than $0.1 million to non-U.S. customers during the six months ended June 30, 2011 and 2010, respectively.
The Company’s net revenues consisted of the following for the three and six months ended June 30, 2011 and 2010:
                                 
    Three Months Ended June 30,     Six Months Ended June 30,  
    2011     2010     2011     2010  
Products:
                               
Acetadote
  $ 12,167,302     $ 8,308,560     $ 20,711,895     $ 16,031,833  
Kristalose
    2,101,971       2,271,418       4,172,352       4,581,401  
Caldolor
    86,027       45,776       97,981       65,081  
Other
    34,441       114,181       74,440       192,272  
 
                       
Total net revenues
  $ 14,389,741     $ 10,739,935     $ 25,056,668     $ 20,870,587